DILUMAREX
Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
20-03-2012
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
water for injection 1 ml
Available from:
Merial
ATC code:
QV07AB
Pharmaceutical form:
Solution for injection
Therapeutic group:
Solvents and diluting agents, incl. irrigating solutions
Therapeutic area:
Chicken
Authorization date:
2009-11-20
Summary of Product characteristics
October 2009
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
DILUMAREX
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Aqueous
diluent............................................................................................................................q.s. 1 ml
3.
PHARMACEUTICAL FORM
Solution for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Chickens.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In chickens:
For the suspension preparation of MERIAL frozen vaccines against Marek’s disease.
4.3
CONTRAINDICATIONS
Do not use alone.
4.4
SPECIAL WARNINGS
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Read special precautions for use of MERIAL frozen vaccines against Marek’s disease.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL
PRODUCT TO ANIMALS
In the case of accidental self-injection, seek medical advice immediately and show the package leaflet
or the label to the physician.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Read corresponding information of MERIAL frozen vaccines against Marek’s disease.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Refer to posology and method of administration of MERIAL frozen vaccines against Marek’s disease.
4.10 OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES), IF NECESSARY
None.
4.11 WITHDRAWAL PERIOD(S)
Zero days.
Read the complete document
